Longrange is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 1 US drug patent filed in 2019. All patents have expired. Details of Longrange’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6733767 | Active | |
Exclusivity Information
Longrange holds 1 exclusivity out of which 1 has expired. Details of Longrange's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Sep 26, 2014 |
About Longrange
Longrange is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Longrange uses
Eprinomectin as the active
ingredient.
Active Ingredient:
Longrange uses
Eprinomectin as the active ingredient.
Check out other Drugs and Companies using
Eprinomectin ingredient.